FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christiane Auray-Blais

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Biological Markers

Procedures

Physiology

Living Beings

Co-author Network

Publications

TOP 3
Pamela Lavoie; Michel Boutin; Christiane Auray-Blais
Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.
F O Dupont; R Gagnon; M Boutin; Christiane Auray-Blais
A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.
Michel Boutin; René Gagnon; Pamela Lavoie; Christiane Auray-Blais
LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christiane Auray-Blais (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pamela Lavoie; Michel Boutin; Christiane Auray-Blais
Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.
Analytical chemistry 2013;85(3):1743-52.
2013: F O Dupont; R Gagnon; M Boutin; Christiane Auray-Blais
A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.
Current medicinal chemistry 2013;20(2):280-8.
2012: Michel Boutin; René Gagnon; Pamela Lavoie; Christiane Auray-Blais
LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease.
Clinica chimica acta; international journal of clinical chemistry 2012;414():273-80.
2012: Ifat Bar-joseph; Anelia Benarrosh; Michal Dekel; Maya Dushnitzky; Roselyne Garnotel; Philippe Gillery; Nurit Goldstein; Niklaus Hofliger; Dina Marek-Yagel; Ben Pode-Shakked; Elon Pras; Haike Reznik-Wolf; Shlomit Rienstein; J Zlotnik; Almogit Abu-Horvitz; Christiane Auray-Blais; Yair Anikster
Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia.
Human genetics 2012;131(11):1805-10.
2012: Christiane Auray-Blais; Joe T R Clarke; René Gagnon; Pamela Lavoie; Bruno Maranda; Sarah P Young; Haoyue Zhang; Yan An; David S Millington
An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.
Clinica chimica acta; international journal of clinical chemistry 2012;413(7-8):771-8.
2012: Christiane Auray-Blais; Michel Boutin; Félix O Dupont; René Gagnon; Pamela Lavoie; Joe T R Clarke
Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.
Analytical chemistry 2012;84(6):2745-53.
2012: Christiane Auray-Blais; M Boutin
Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic study.
Current medicinal chemistry 2012;19(19):3241-52.
2011: F O Dupont; R Gagnon; J Ménard; Christiane Auray-Blais; Jean-Luc Ardilouze
Evaluation of the glycemic control in neonates: a novel technical approach for measuring fetal-glycated hemoglobin.
Journal of perinatology : official journal of the California Perinatal Association 2011;31(12):807; author reply 808.
2011: Félix O Dupont; René Gagnon; Jean-Luc Ardilouze; Christiane Auray-Blais
Determination of glycated and acetylated hemoglobins in cord blood by time-of-flight mass spectrometry.
Analytical chemistry 2011;83(13):5245-52.
2011: Haoyue Zhang; Christiane Auray-Blais; Paul J Orchard; Jakub Tolar; Sarah P Young; David S Millington
Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
Clinical chemistry 2011;57(7):1005-12.
2011: Charles G Bailey; Renae M Ryan; Annora D Thoeng; Cynthia Ng; Kara King; Jessica M Vanslambrouck; Christiane Auray-Blais; Robert J Vandenberg; Stefan Broer; John Rasko
Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.
The Journal of clinical investigation 2011;121(1):446-53.
2011: Christiane Auray-Blais; Patrick Bhérer; René Gagnon; Sarah P Young; Haoyue H Zhang; Yan An; Joe T R Clarke; David S Millington
Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
Molecular genetics and metabolism 2011;102(1):49-56.
2010: Christiane Auray-Blais; Aimé Ntwari; Joe T R Clarke; David G Warnock; João Paulo Oliveira; Sarah P Young; David S Millington; Daniel G Bichet; Sandra Sirrs; Michael L West; Robin Casey; Wuh-Liang Hwu; Joan M Keutzer; X Kate Zhang; René Gagnon
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?
Clinica chimica acta; international journal of clinical chemistry 2010;411(23-24):1906-14.
2010: Raphael Schiffmann; Stephen Waldek; Ariela Benigni; Christiane Auray-Blais
Biomarkers of Fabry disease nephropathy.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(2):360-4.
2009: Caroline Barr; Joe T R Clarke; Aimé Ntwari; Régen Drouin; Christiane Auray-Blais
Fabry disease urinary globotriaosylceramide/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months.
Molecular genetics and metabolism 2009;97(4):278-83.
2009: Christiane Auray-Blais; David S Millington; Caroline Barr; Sarah P Young; Kevin Mills; Joe T R Clarke
Gb(3)/creatinine biomarkers for Fabry disease: issues to consider.
Molecular genetics and metabolism 2009;97(3):237.
2009: Christiane Auray-Blais; D S Millington; S P Young; Joe T R Clarke; R Schiffmann
Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease.
Journal of inherited metabolic disease 2009;32(2):303-8.
2008: Stefan Broer; Charles G Bailey; Sonja Kowalczuk; Cynthia Ng; Jessica M Vanslambrouck; Helen Rodgers; Christiane Auray-Blais; Juleen A Cavanaugh; Angelika Bröer; John Rasko
Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.
The Journal of clinical investigation 2008;118(12):3881-92.
2008: Dimitar N Azmanov; Sonja Kowalczuk; Helen Rodgers; Christiane Auray-Blais; Robert Giguère; John Rasko; Stefan Broer; Juleen A Cavanaugh
Further evidence for allelic heterogeneity in Hartnup disorder.
Human mutation 2008;29(10):1217-21.
2008: Christiane Auray-Blais; Denis Cyr; Aimé Ntwari; Michael L West; J Cox-Brinkman; Daniel G Bichet; Dominique P Germain; Rachel Laframboise; Serge B Melançon; Tracy Stockley; Joe T R Clarke; Régen Drouin
Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.
Molecular genetics and metabolism 2008;93(3):331-40.
2007: Dimitar N Azmanov; Helen Rodgers; Christiane Auray-Blais; Robert Giguère; Charles Bailey; Stefan Broer; John Rasko; Juleen A Cavanaugh
Persistence of the common Hartnup disease D173N allele in populations of European origin.
Annals of human genetics 2007;71(Pt 6):755-61.
2007: Christiane Auray-Blais; Denis Cyr; Régen Drouin
Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules.
Journal of inherited metabolic disease 2007;30(4):515-21.
2007: Christiane Auray-Blais; Johane Patenaude
Biobanking primer: down to basics.
Science (New York, N.Y.) 2007;316(5826):830.
2007: Christiane Auray-Blais; Denis Cyr; K Mills; Robert Giguère; Régen Drouin
Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry disease.
Journal of inherited metabolic disease 2007;30(1):106.
2006: Christiane Auray-Blais; Johane Patenaude
A biobank management model applicable to biomedical research.
BMC medical ethics 2006;7():E4.
2003: Christiane Auray-Blais; Robert Giguère; Bernard Lemieux
Newborn urine screening programme in the province of Quebec: an update of 30 years' experience.
Journal of inherited metabolic disease 2003;26(4):393-402.
1999: L C Sniderman; M Lambert; Robert Giguère; Christiane Auray-Blais; Bernard Lemieux; R Laframboise; D S Rosenblatt; Eileen P Treacy
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program.
The Journal of pediatrics 1999;134(6):675-80.